Showing results (41-50 of 53) with videos related to
Sort By:
Pageof 6
Blood|April 12, 2014
TPL2 kinase regulates the inflammatory milieu of the myeloma nicheChelsea Hope, Samuel J Ollar, Erika Heninger, et al.Proceedings of the National Academy of Sciences of the United States of America|June 10, 2015
Single-molecule analysis reveals widespread structural variation in multiple myelomaAditya Gupta, Michael Place, Steven Goldstein, et al.Leukemia|November 30, 2019
Pre-clinical activity of combined LSD1 and mTORC1 inhibition in MLL-translocated acute myeloid leukaemiaGauri Deb, Bettina Wingelhofer, Fabio M R Amaral, et al.Genes & Development|August 10, 2019
Rationale for targeting BCL6 in <i>MLL</i>-rearranged acute lymphoblastic leukemiaChristian Hurtz, Lai N Chan, Huimin Geng, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 21, 2023
Heart-liver-kidney transplantation for AL amyloidosis using normothermic recovery and storage from a donor following circulatory death: Short-term outcome in a first-in-world experienceAleah L Brubaker, Marcus A Urey, Raeda Taj, et al.Journal of Medicinal Chemistry|January 10, 2017
Design of a Biased Potent Small Molecule Inhibitor of the Bromodomain and PHD Finger-Containing (BRPF) Proteins Suitable for Cellular and in Vivo StudiesNiall Igoe, Elliott D Bayle, Oleg Fedorov, et al.Transplantation and Cellular Therapy|May 23, 2022
Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune and Cellular Therapy in Multiple MyelomaSarah A Holstein, Fotis Asimakopoulos, Abdel Kareem Azab, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2026
Tumor matrix proteoglycan accumulation and processing alters T cell effector function and the response to immunotherapy in patients with oligometastatic colorectal cancerDustin A Deming, Sean G Kraus, Joshua Brand, et al.Nature|July 24, 2020
Signalling input from divergent pathways subverts B cell transformationLai N Chan, Mark A Murakami, Mark E Robinson, et al.Nature|November 5, 2020
IFITM3 functions as a PIP3 scaffold to amplify PI3K signalling in B cellsJaewoong Lee, Mark E Robinson, Ning Ma, et al.Pageof 6